Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Group A streptococci (GAS) produce several exoproteins that are thought to contribute to the pathogenesis of human infection. Two such proteins, streptolysin O (SLO) and NAD(+)-glycohydrolase (
NADase
), have been shown to interact functionally as a compound signaling toxin. When GAS are bound to the surface of epithelial cells in vitro, SLO forms pores in the cell membrane and delivers
NADase
to the epithelial cell cytoplasm. In vitro, intoxication of keratinocytes with
NADase
is associated with cytotoxic effects and induction of apoptosis; however, the importance of
NADase
during infection of an animal host has not been established. We employed isogenic GAS mutants to assess the contribution of
NADase
activity to GAS virulence in vivo using mouse models of invasive soft-tissue infection and
septicemia
. In both models, mutant GAS that lacked
NADase
activity were significantly attenuated for virulence compared with the isogenic wild-type parent, confirming an important role for
NADase
in the infection of a host animal. A double mutant lacking SLO and
NADase
activity had an intermediate virulence phenotype, consistent with the hypothesis that SLO evokes a protective innate immune response. We conclude that
NADase
and SLO together enhance GAS virulence in vivo.
...
PMID:Role of NADase in virulence in experimental invasive group A streptococcal infection. 1617 31